Business Description
Everest Organics Ltd
ISIN : INE334C01029
Total Employee Number:
355Compare
Compare
Traded in other countries / regions
524790.India IPO Date
2000-11-27Description
Everest Organics Ltd is a pharmaceutical company. It is focused on manufacturing active pharmaceutical ingredients and intermediaries. The products offered by the company include Omeprazole, Ciprofloxacin, Dichloroflurobenzene, Naproxen, Benzimadizole, and others. The company operates in one primary business segment namely Active Pharmaceutical Ingredients (API) and their intermediaries. Geographically, it derives a majority of its revenue from India.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.02 | |||||
Equity-to-Asset | 0.32 | |||||
Debt-to-Equity | 0.66 | |||||
Debt-to-EBITDA | 2.37 | |||||
Interest Coverage | 2.04 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 2.18 | |||||
Beneish M-Score | -1.96 | |||||
WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -4.4 | |||||
3-Year EBITDA Growth Rate | 31.7 | |||||
3-Year FCF Growth Rate | -46.1 | |||||
3-Year Book Growth Rate | 10.4 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 61.92 | |||||
9-Day RSI | 56.97 | |||||
14-Day RSI | 56.37 | |||||
3-1 Month Momentum % | 2.34 | |||||
6-1 Month Momentum % | -33.57 | |||||
12-1 Month Momentum % | -14.6 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 1.1 | |||||
Quick Ratio | 0.81 | |||||
Cash Ratio | 0.01 | |||||
Days Inventory | 126.11 | |||||
Days Sales Outstanding | 198.5 | |||||
Days Payable | 282.74 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -6.7 | |||||
Shareholder Yield % | 0.84 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.11 | |||||
Operating Margin % | 6.79 | |||||
Net Margin % | 2.83 | |||||
EBITDA Margin % | 10.74 | |||||
FCF Margin % | 0.48 | |||||
OCF Margin % | 2.13 | |||||
ROE % | 7.64 | |||||
ROA % | 2.37 | |||||
ROIC % | 6.82 | |||||
ROC (Joel Greenblatt) % | 12.52 | |||||
ROCE % | 16.86 | |||||
Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 54.92 | |||||
PE Ratio without NRI | 54.92 | |||||
Shiller PE Ratio | 47.7 | |||||
PS Ratio | 1.55 | |||||
PB Ratio | 4.03 | |||||
Price-to-Tangible-Book | 4.16 | |||||
Price-to-Free-Cash-Flow | 324.73 | |||||
Price-to-Operating-Cash-Flow | 72.97 | |||||
EV-to-EBIT | 23.83 | |||||
EV-to-EBITDA | 16.48 | |||||
EV-to-Revenue | 1.77 | |||||
EV-to-FCF | 368.37 | |||||
Price-to-GF-Value | 2.37 | |||||
Price-to-Projected-FCF | 4.56 | |||||
Price-to-Median-PS-Value | 1.41 | |||||
Price-to-Graham-Number | 3.15 | |||||
| Price-to-Net-Current-Asset-Value | 95.98 | |||||
Earnings Yield (Greenblatt) % | 4.2 | |||||
FCF Yield % | 0.32 | |||||
Forward Rate of Return (Yacktman) % | -4.39 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Everest Organics Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,961.577 | ||
| EPS (TTM) (₹) | 5.7 | ||
| Beta | 1.9719 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 1.41 | ||
| Volatility % | 73.54 | ||
| 14-Day RSI | 56.37 | ||
| 14-Day ATR (₹) | 19.442883 | ||
| 20-Day SMA (₹) | 306.43 | ||
| 12-1 Month Momentum % | -14.6 | ||
| 52-Week Range (₹) | 197 - 536.4 | ||
| Shares Outstanding (Mil) | 9.71 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Everest Organics Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Everest Organics Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Everest Organics Ltd Frequently Asked Questions
What is Everest Organics Ltd(BOM:524790)'s stock price today?
The current price of BOM:524790 is ₹307.15. The 52 week high of BOM:524790 is ₹536.40 and 52 week low is ₹197.00.
When is next earnings date of Everest Organics Ltd(BOM:524790)?
The next earnings date of Everest Organics Ltd(BOM:524790) is .
Does Everest Organics Ltd(BOM:524790) pay dividends? If so, how much?
Everest Organics Ltd(BOM:524790) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Everest Organics Ltd
No articles.